StemCell Therapy

The 5th International Conference on Tissue Engineering & Regenerative Medicine which is going to be held during September 12-14, 2016 at Berlin, Germany will bring together world-class personalities working on stem cells, tissue engineering and regenerative medicine to discuss materials-related strategies for disease remediation and tissue repair.

Tissue Regeneration

In the field of biology, regeneration is the progression of renewal, regeneration and growth that makes it possible for genomes, cells, organ regeneration to natural changes or events that cause damage or disturbance.This study is carried out as craniofacial tissue engineering, in-situ tissue regeneration, adipose-derived stem cells for regenerative medicine which is also a breakthrough in cell culture technology. The study is not stopped with the regeneration of tissue where it is further carried out in relation with cell signaling, morphogenetic proteins. Most of the neurological disorders occurred accidental having a scope of recovery by replacement or repair of intervertebral discs repair, spinal fusion and many more advancements. The global market for tissue engineering and regeneration products such as scaffolds, tissue implants, biomimetic materials reached $55.9 billion in 2010 and it is expected to reach $89.7 billion by 2016 at a compounded annual growth rate (CAGR) of 8.4%. It grows to $135 billion by 2024.

Related Conferences

International Conference on Cancer Immunology and Immunotherapy July 28-30, 2016 Melbourne, Australia; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 5th International Conference on Tissue Science and Regenerative Medicine September 12-14, 2016 Berlin, Germany; 6th World Congress on Cell & Stem Cell Research February 29-March 02, 2016 Philadelphia, USA; 5th International Conference and Exhibition on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; Tissue Niches & Resident Stem Cells in Adult Epithelia Gordon Research Conference, Regulation of Tissue Homeostasis by Signaling in the Stem Cell Niche August 7-12,Hong Kong, China; 10 Years of IPSCs, Cell Symposia, September 25-27, 2016Berkeley, CA, USA; The Company of Biologists Workshops: From Stem Cells to Human Development September 25-28, 2016Southbridge, MA, USA; World Stem Cells & Regenerative Medicine Congress May 18-20, 2016 London, UK; Notch Signaling in Development, Regeneration & Disease Gordon Research Conference, July 31-August 5, 2016Lewiston, ME, USA

Designs for Tissue Engineering

The developing field of tissue engineering aims to regenerate damaged tissues by combining cells from the body with bioresorbable materials, biodegradable hydrogel, biomimetic materials, nanostructures and nanomaterials, biomaterials and tissue implants which act as templates for tissue regeneration, to guide the growth of new tissue by using with the technologies. The global market for biomaterials, nanostructures and bioresorbable materials are estimated to reach $88.4 billion by 2017 from $44.0 billion in 2012 growing at a CAGR of 15%. Further the biomaterials market estimated to be worth more than 300 billion US Dollars and to be increasing 20% per year.

Related Conferences

6th World Congress on Cell & Stem Cell Research February 29-March 02, 2016 Philadelphia, USA; 5th International Conference and Exhibition on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 2nd International Conference & Exhibition on Tissue preservation and Bio-banking August 18-19, 2016 Portland, USA; ISSCR 14th Annual Meeting 22-25 June, 2016San Francisco, California, USA; Keystone Cardiac Development, Regeneration and Repair (Z2) April 3 7, 2016Snowbird, Utah, USA; The Stem Cell NicheDevelopment & Disease May 22-26, 2016Hillerd, Denmark; EMBL Hematopoietic Stem Cells: From the Embryo to the Aging Organism, June 3-5, 2016Heidelberg, Germany; ISSCR Pluripotency: From basic science to therapeutic applications March 22-24, 2016 Kyoto, Japan

Organ Engineering

This interdisciplinary engineering has attracted much attention as a new therapeutic means that may overcome the drawbacks involved in the current artificial organs and organ transplantation that have been also aiming at replacing lost or severely damaged tissues or organs. Tissue engineering and regenerative medicine is an exciting research area that aims at regenerative alternatives to harvested tissues for organ transplantation with soft tissues. Although significant progress has been made in the tissue engineering field, many challenges remain and further development in this area will require ongoing interactions and collaborations among the scientists from multiple disciplines, and in partnership with the regulatory and the funding agencies. As a result of the medical and market potential, there is significant academic and corporate interest in this technology.

Related Conferences

International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA; 5th International Conference and Exhibition on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; 6th World Congress on Cell & Stem Cell Research February 29-March 02, 2016 Philadelphia, USA; 5th International Conference on Tissue Science and Regenerative Medicine September 12-14, 2016 Berlin, Germany;2ndInternational Conference & Exhibition on Tissue preservation and Bio-banking August 18-19, 2016 Portland, USA;Phacilitate Cell & Gene Therapy WorldJanuary 25-27, 2016Washington D.C., USA;ISSCR Stem Cell Models of Neural Degeneration and DiseaseFebruary 1-3, 2016Dresden, Germany;Craniofacial Morphogenesis & Tissue RegenerationMarch 12-18, 2016California, USA;Keystone Stem Cells and Cancer (C1)March 6-10,Colorado, USA;Keystone Stem Cells and Regeneration in the Digestive Organs (X6)March 13 17Colorado, USA

CancerStem Cells

The characterization of cancer stem cell is done by identifying the cell within a tumor that possesses the capacity to self-renew and to cause the heterogeneous lineages of cancer cells that comprise the tumor. This stem cell which acts as precursor for the cancer acts as a tool against it indulging the reconstruction of cancer stem cells, implies as the therapeutic implications and challenging the gaps globally. The global stem cell market will grow from about $5.6 billion in 2013 to nearly $10.6 billion in 2018, registering a compound annual growth rate (CAGR) of 3.6% from 2013 through 2018. The Americas is the largest region of global stem cell market, with a market share of about $2.0 billion in 2013. The region is projected to increase to nearly $3.9 billion by 2018, with a CAGR of 13.9% for the period of 2013 to 2018. Europe is the second largest segment of the global stem cell market and is expected to grow at a CAGR of 13.4% reaching about $2.4 billion by 2018 from nearly $1.4 billion in 2013.

Related Conferences

6th World Congress on Cell & Stem Cell Research February 29-March 02, 2016 Philadelphia, USA; 5th International Conference and Exhibition on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 5th International Conference on Tissue Science and Regenerative Medicine September 12-14, 2016 Berlin, Germany;2ndInternational Conference & Exhibition on Tissue preservation and Bio-banking August 18-19, 2016 Portland, USA; Molecular and Cellular Basis of Growth and Regeneration (A3) January 10 14, 2016Colorado, USA; Phacilitate Cell & Gene Therapy World January 25-27, 2016Washington D.C., USA; ISSCR Stem Cell Models of Neural Degeneration and Disease March 13 17, 2016Dresden, Germany; Craniofacial Morphogenesis & Tissue Regeneration March 12-18, 2016California, USA; World Stem Cells & Regenerative Medicine Congress May 18-20, 2016 London, UK

Bone Tissue Engineering

Tissue engineering of musculoskeletal tissues, particularly bone and cartilage, is a rapidly advancing field. In bone, technology has centered on bone graft substitute materials and the development of biodegradable scaffolds. Recently, tissue engineering strategies have included cell and gene therapy. The availability of growth factors and the expanding knowledge base concerning the bone regeneration with modern techniques like recombinant signaling molecules, solid free form fabrication of scaffolds, synthetic cartilage, Electrochemical deposition, spinal fusion and ossification are new generated techniques for tissue-engineering applications. The worldwide market for bone and cartilage repairs strategies is estimated about $300 million. During the last 10/15 years, the scientific community witnessed and reported the appearance of several sources of stem cells with both osteo and chondrogenic potential.

Related Conferences

5th International Conference on Tissue Science and Regenerative Medicine September 12-14, 2016 Berlin, Germany; 6th World Congress on Cell & Stem Cell Research February 29-March 02, 2016 Philadelphia, USA; 3rd2nd International Conference & Exhibition on Tissue preservation and Bio-banking August 18-19, 2016 Portland, USA; 5th International Conference and Exhibition on Cell and Gene Therapy May 19-21, 2016 San Antonio, USA; International Conference on Restorative Medicine October 24-26, 2016 Chicago, USA;10th World Biomaterials Congress May 17-22, 2016 Quebec, Canada;2016 TERMIS-EU Conference June 28- July1, 2016 Uppsala, Sweden; 2016 TERMIS-AP Conference Tamsui Town of New Taipei CityMay 23-28, 2016;2016 TERMIS-AM Conference September 3-6, 2016, San Diego, USA; Pluripotency: From basic science to therapeutic applications 22-24 March 2016 Kyoto, Japan

Scaffolds

Scaffolds are one of the three most important elements constituting the basic concept of regenerative medicine, and are included in the core technology of regenerative medicine. Every day thousands of surgical procedures are performed to replace or repair tissue that has been damaged through disease or trauma. The developing field of tissue engineering (TE) aims to regenerate damaged tissues by combining cells from the body with highly porous scaffold biomaterials, which act as templates for tissue regeneration, to guide the growth of new tissue. Scaffolds has a prominent role in tissue regeneration the designs, fabrication, 3D models, surface ligands and molecular architecture, nanoparticle-cell interactions and porous of the scaffolds are been used in the field in attempts to regenerate different tissues and organs in the body. The world stem cell market was approximately 2.715 billion dollars in 2010, and with a growth rate of 16.8% annually, a market of 6.877 billion dollars will be formed in 2016. From 2017, the expected annual growth rate is 10.6%, which would expand the market to 11.38 billion dollars by 2021.

Related Conferences

4th International Congress on Bacteriology and Infectious Diseases May 16-18, 2016 San Antonio, USA; 2nd World Congress and Expo on Applied Microbiology October 31-November 02, 2016 Istanbul, Turkey; International Conference on Infectious Diseases & Diagnostic Microbiology Oct 3-5, 2016 Vancouver, Canada; International Conference on Water Microbiology & Novel Technologies July 18-20, 2016 Chicago, USA; 5th International Conference on Clinical Microbiology and Microbial Genomics October 24-26, 2016 Rome, Italy; Annual Meeting of the German Society for Gene Therapy 12 - 13 March 2015 Vienna, Austria; International Bone-Tissue-Engineering Congress 8 - 10 October 2015. Stuttgart, Germany; Till & McCulloch Meetings October 26-28, 2015 Toronto, Canada; 9th International Symposium on Neuroprotection and Neurorepair April 19 to April 22, 2016 Magdeburg, Germany; Craniofacial Morphogenesis & Tissue Regeneration March 12-18, 2016California, USA

Tissue Regeneration Technologies

Guided tissue regeneration is defined as procedures attempting to regenerate lost periodontal structures through differential tissue responses. Guided bone regeneration typically refers to ridge augmentation or bone regenerative procedures it typically refers to regeneration of periodontal therapy. The recent advancements and innovations in biomedical and regenerative tissue engineering techniques include the novel approach of guided tissue regeneration and combination of nanotechnology and regenerative medicine.

Related Conferences

3rd International Conference on Gynecology & Obstetrics October 17-19, 2016 Dubai, UAE; 5th International Conference on Tissue Science and Regenerative Medicine September 12-14, 2016 Berlin, Germany; 6th World Congress on Cell & Stem Cell Research February 29-March 02, 2016 Philadelphia, USA; 2nd International Conference & Exhibition on Tissue preservation and Bio-banking August 18-19, 2016 Portland, USA; International Conference on Restorative Medicine October 24-26, 2016 Chicago; 2016 Annual Convention & Exposition June 6-9, 2016 Philadelphia, USA;3rd International Conference on BioTribology - ICoBT 2016 September 11-14, 2016 London, UK; International Symposium on Endovascular Therapy - ISET February 6-10, 2016Florida, USA; International Bone Tissue Engineering Congress October 810 , 2015Stuttgart, Germany

Regeneration and Therapeutics

Regenerative medicinecan be defined as a therapeutic intervention which replaces or regenerates human cells, tissues or organs, to restore or establish normal function and deploys small molecule drugs, biologics, medical devices and cell-based therapies. It deals with the different therapeutic uses like stem cells for tissue repair, tissue injury and healing process, cardiac stem cell therapy for regeneration, functional regenerative recovery, effects of aging on tissue repair/regeneration, corneal regeneration & degeneration. The global market is expected to reach $25.5 billion by 2011 and will further grow to $36.1 billion by 2016 at a CAGR of 7.2%. It is expected to reach $65 billion mark by 2024.

Related Conferences

World Congress on Human Genetics October 31- November 02, 2016 Valencia, Spain; 5th International Conference on Tissue Science and Regenerative Medicine September 12-14, 2016 Berlin, Germany; 2nd International Conference & Exhibition on Tissue preservation and Bio-banking August 18-19, 2016 Portland, USA; European Conference on Genomics and Personalized Medicine April 25-27, 2016 Valencia, Spain; 4th International Conference on Plant Genomics July 14-15, 2016 Brisbane, Australia; World Stem Cells & Regenerative Medicine Congress May 18-20, 2016 London, UK; 18th International Conference on Tissue Engineering and Regenerative Medicine Applications May 12 - 13, 2016 Amsterdam, Netherlands; 18th International Conference on Bone, Muscle and Joint Diseases February 25 - 26, 2016 London, UK; 2nd Conference on Tissue Engineering and Regenerative Medicine March 18 to 20, 2016 Los Angeles, USA;

Regenerative medicine

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function. The latest developments involve advances in cell and gene therapy and stem cell research, molecular therapy, dental and craniofacial regeneration. Regenerative medicines have the unique ability to repair, replace and regenerate tissues and organs, affected due to some injury, disease or due to natural aging process. These medicines are capable of restoring the functionality of cells and tissues. The global regenerative medicine market will reach $ 67.6 billion by 2020 from $16.4 billion in 2013, registering a CAGR of 23.2% during forecast period (2014 - 2020). Small molecules and biologics segment holds prominent market share in the overall regenerative medicine technology market and is anticipated to grow at a CAGR of 18.9% during the forecast period.

Related Conferences

International Conference on Next Generation Sequencing July 21-22, 2016 Berlin, Germany; 5th International Conference on Computational Systems Biology August 22-23, 2016 Philadelphia, USA; 7th International Conference on Bioinformatics October 27-28, 2016 Chicago, USA; International Conference on Synthetic Biology September 28-30, 2015 Houston, USA; 4th International Conference on Integrative Biology July 18-20, 2016 Berlin, Germany; World Conference on Regenerative Medicine October 2123, 2015 Lepizig, Germany; World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases April 14-17 2016 Malga, Spain; Bioinspired Materials Gordon Research Conference June 5-10, 2016, Girona, Spain

Applications of Tissue Engineering

The applications of tissue engineering and regenerative medicine are innumerable as they mark the replacement of medication and organ replacement. The applications involve cell tracking and tissue imaging, cell therapy and regenerative medicine, organ harvesting, transport and transplant, the application of nanotechnology in tissue engineering and regenerative medicine and bio banking. Globally the research statistics are increasing at a vast scale and many universities and companies are conducting events on the subject regenerative medicine conference like tissue implants workshops, endodontics meetings, tissue biomarkers events, tissue repair meetings, regenerative medicine conferences, tissue science conference, regenerative medicine workshop, veterinary regenerative medicine, regenerative medicine symposiums, tissue regeneration conferences, regenerative medicine congress.

Related Conferences

World Congress on Human Genetics October 31- November 02, 2016 Valencia, Spain; 5th International Conference on Tissue Science and Regenerative Medicine September 12-14, 2016 Berlin, Germany; 2nd International Conference & Exhibition on Tissue preservation and Bio-banking August 18-19, 2016 Portland, USA; European Conference on Genomics and Personalized Medicine April 25-27, 2016 Valencia, Spain; 4th International Conference on Plant Genomics July 14-15, 2016 Brisbane, Australia; Biocatalysis (GRS) Gordon Research Seminar Jul 9-10, 2016 New England, UK; World Conference on Regenerative Medicine October 2123, 2015 Lepizig, Germany; 18thInternational Conference on Tissue Engineering and Regenerative Medicine Applications May 12 - 13, 2016 Amsterdam, Netherlands; International Bone-Tissue-Engineering Congress 8 - 10 October 2015. Stuttgart, Germany; Craniofacial Morphogenesis & Tissue Regeneration March 12-18, 2016California, USA.

Market Analysis in Regenerative Medicine:

There are strong pricing pressures from public healthcare payers globally as Governments try to reduce budget deficits. Regenerative medicine could potentially save public health bodies money by reducing the need for long-term care and reducing associated disorders, with potential benefits for the world economy as a whole.The global market for tissue engineering and regeneration products reached $55.9 billion in 2010, is expected to reach $59.8 billion by 2011, and will further grow to $89.7 billion by 2016 at a compounded annual growth rate (CAGR) of 8.4%. It grows to $135 billion to 2024. The contribution of the European region was 43.3% of the market in 2010, a value of $24.2 billion. The market is expected to reach $25.5 billion by 2011 and will further grow to $36.1 billion by 2016 at a CAGR of 7.2%. It grows to $65 billion to 2024.

Related Conferences

2ndInternational Conference & Exhibition on Tissue preservation andBio-bankingAugust 18-19, 2016 Portland, USA; European Conference on Genomics andPersonalized MedicineApril 25-27, 2016 Valencia, Spain;3rdInternational Conference onGynecology& Obstetrics October 17-19, 2016 Dubai, UAE; 5thInternational Conference on Tissue Science andRegenerative MedicineSeptember 12-14, 2016 Berlin, Germany; 6thWorld Congress on Cell &Stem Cell ResearchFebruary 29-March 02, 2016 Philadelphia, USA;18thInternational Conference on Bone, Muscle andJoint DiseasesFebruary 25 - 26, 2016 London, UK; 2ndConference on Tissue Engineering andRegenerative MedicineMarch 18 to 20, 2016 Los Angeles, USA;InternationalBone-Tissue-Engineering Congress 8 - 10 October 2015. Stuttgart, Germany; CraniofacialMorphogenesis& Tissue Regeneration March 12-18, 2016California, USA.

Market Analysis Report:

Tissue engineering is an interdisciplinary field that applies the principles of engineering and life sciences toward the development of biological substitutes that restore, maintain, or improve tissue function or a whole organ. Regenerative medicine is not one discipline. It can be defined as a therapeutic intervention which replaces or regenerates human cells, tissues or organs, to restore or establish normal function and deploys small molecule drugs, biologics, medical devices and cell-based therapies

Currently it has emerged as a rapidly diversifying field with the potential to address the worldwide organ shortage issue and comprises of tissue regeneration and organ replacement. Regenerative medicine could potentially save public health bodies money by reducing the need for long-term care and reducing associated disorders, with potential benefits for the world economy as a whole.The global tissue engineering and regeneration market reached $17 billion in 2013. This market is expected to grow to nearly $20.8 billion in 2014 and $56.9 billion in 2019, a compound annual growth rate (CAGR) of 22.3%. On the basis of geography, Europe holds the second place in the global market in the field of regenerative medicine & tissue engineering. In Europe countries like UK, France and Germany are possessing good market shares in the field of regenerative medicine and tissue engineering. Spain and Italy are the emerging market trends for tissue engineering in Europe.

Tissue engineering is "an interdisciplinary field that applies the principles of engineering and life sciences toward the development of biological substitutes that restore, maintain, or improve tissue function or a whole organ. Currently it has emerged as a rapidly diversifying field with the potential to address the worldwide organ shortage issue and comprises of tissue regeneration and organ replacement. A novel set of tissue replacement parts and implementation strategies had shown a great revolution in this field. Cells placed on or within the tissue constructs is the most common methodology in tissue engineering.

Regenerative medicine is not one discipline. It can be defined as a therapeutic intervention which replaces or regenerates human cells, tissues or organs, to restore or establish normal function and deploys small molecule drugs, biologics, medical devices and cell-based therapies

This field continues to evolve. In addition to medical applications, non-therapeutic applications include using tissues as biosensors to detect biological or chemical threat agents, and tissue chips that can be used to test the toxicity of an experimental medication. Tissue Engineering and Regenerative Medicine is the major field in Medicine, which is still under research and the advancements are maximizing day to day.

Regenerative Medicine-2015 is an engrossed a vicinity of cognizant discussions on novel subjects like Tissue Regeneration, Materials & Designs for Tissue Engineering, Stem CellTools to Battle Cancer, Bioreactors in Tissue Engineering, Regeneration & Therapeutics, Cord Blood & Regenerative Medicine and Clinical Medicine, to mention a few. The three days event implants a firm relation of upcoming strategies in the field of Tissue Science & Regenerative Medicine with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.We bring together business, creative, and technology leaders from the tissue engineering, marketing, and research industry for the most current and relevant.

Berlin is one of the largest and most diverse science regions in Europe. Roughly 200,000 people from around the world teach, research, work and study here. Approximately 17 percent of all students come from abroad, most of them from China, Russia and the USA. Many cooperative programs link Berlins institutes of higher education with partner institutes around the world. Berlin is a city of science at the heart of Europe a city whose history of scientific excellence stems from its many important research institutions and its long track record of scientific breakthroughs. Berlin has numerous modern Technology Centers. Their science-oriented infrastructure makes them attractive locations for young, technology-oriented companies.

Germany places great emphasis on globally networked research cooperation. Many organizations support international researchers and academics: Today more than 32,000 are being supported with scholarships. Besides this, research funding in Germany has the goal of financing the development of new ideas and technologies. The range covers everything from basic research in natural sciences, new technologies to structural research funding at institutions of higher education. On the basis of geography, the regenerative medicine bone and joint market Europe hold the second place in the global market in the field of regenerative medicine & tissue engineering. The market growth is expected to reach $65 billion by 2024 in Europe. In Europe countries like UK, France, and Germany are possessing good market share in the field of regenerative medicine and tissue engineering. Spain and Italy are the emerging market trends for tissue engineering in Europe. As per the scope and emerging market for tissue engineering and regenerative medicine Berlin has been selected as Venue for the 5th International Conference on Tissue Science and Regenerative Medicine.

Meet Your Target MarketWith members from around the world focused on learning about Advertising and marketing, this is the single best opportunity to reach the largest assemblage of participants from the tissue engineering and regenerative medicine community. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Tissue Regeneration, Materials & Designs for Tissue Engineering, Stem CellTools to Battle Cancer, Bioreactors in Tissue Engineering, Regeneration & Therapeutics, Cord Blood & Regenerative Medicine and Clinical Medicine, to mention a few. The three days event implants a firm relation of upcoming strategies in the field of Tissue Engineering & Regenerative Medicine with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.Conduct demonstrations, distribute information, meet with current and potential customers, make a splash with a new product line, and receive name recognition.

International Stem Cell Forum (ISCF)

International Society for Stem Cell Research (ISSCR)

UK Medical Research Council (MRC)

Australian Stem Cell Center

Canadian Institutes of Health Research (CIHR)

Euro Stem Cell (ACR)

Center for Stem Cell Biology

Stem Cell Research Singapore

UK National Stem Cell Network

Spain Mobile Marketing Association

European Marketing Confederation (EMC)

European Letterbox Marketing Association(ELMA)

European Sales & Marketing Association (ESMA)

The Incentive Marketing Association (IMA Europe)

European Marketing Academy

Figure 1: Statistical Analysis of Societies and Associations

Source: Reference7

Presidents or Vice Presidents/ Directors of Associations and Societies, CEOs of the companies associated with regenerative medicine and tissue engineering Consumer Products. Retailers, Marketing, Advertising and Promotion Agency Executives, Solution Providers (digital and mobile technology, P-O-P design, retail design, and retail execution), Professors and Students from Academia in the study of Marketing and Advertising filed.

Industry 40%

Academia 50%

Others 10%

Figure 2: Target Audience

Technische University Munchen

University of Wrzburg

University Medical Center

University of Tubingen

Universittsklinikum Mnster

Technische Universitt Dresden

Leipzig University

University Medicine of Rostock

Institut fur Humangenetik und Anthropologie der Universitat

Otto-von-Guericke University

Hannover Medical School

Max Planck Institute

Figure 3: Top Universities in Germany

There are strong pricing pressures from public healthcare payers globally as Governments try to reduce budget deficits. Regenerative medicine could potentially save public health bodies money by reducing the need for long-term care and reducing associated disorders, with potential benefits for the world economy as a whole.The global market for tissue engineering and regeneration products reached $55.9 billion in 2010, is expected to reach $59.8 billion by 2011, and will further grow to $89.7 billion by 2016 at a compounded annual growth rate (CAGR) of 8.4%. It grows to $135 billion to 2024

The contribution of the European region was 43.3% of the market in 2010, a value of $24.2 billion. The market is expected to reach $25.5 billion by 2011 and will further grow to $36.1 billion by 2016 at a CAGR of 7.2%. It grows to $65 billion to 2024. [Source: Reference2]

Figure 4: Global Market Growth of Tissue Engineering and Regenerative Medicine

Figure 5: Industries associated with Tissue Engineering and Regenerative Medicine

More:
Regenerative Medicine Conferences | Europe | Worldwide ...

This entry was posted on August 4, 2016 at 9:40 am and is filed under Regenerative Medicine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |